TargetCancer Foundation

: Meet the Mintz Project Analysts!

As part of our longstanding relationship, Mintz assigns two Project Analysts (PAs) to TCF each year to provide critical volunteer support for our annual fundraising events.

This year, Shruthi and Emma spent months securing donations and organizing our silent auction leading up to A Night to Strike Out Rare Cancer at Fenway Park. On the night of the event, they coordinated their fellow PAs to expertly handle check-in, check-out, and everything in between.

We're incredibly grateful to Shruthi, Emma, Grace, Jessica, Jordyn, Judy, Miya, Sneha, and Wish for your incredible dedication. We couldn't do this without you! 🙌

Thank you, Mintz, for partnering with us to support the rare cancer community! 💚

What happens when you put patients at the center of cancer research? Better options and better outcomes.

At our 4th annual Think Tank on Advancing Precision Medicine in Rare Cancers, experts in precision oncology explored how clinical trials are evolving from one-size-fits-all approaches to patient-centric models.

Watch Dr. Razelle Kurzrock, Dr. Young Kwang Chae, TCF CEO Jim Palma, and Dr. Jens Rueter discuss how precision medicine, flexible trial designs, and real-world data can make trials more accessible, faster, and more relevant for rare cancer patients.

🔗 From Drug Centric to Patient-Centric Precision Medicine & Immunotherapy Trials in Rare Cancers: https://targetcancer.short.gy/SsLIep